Atlas Trials

Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors

Clinical trial NCT01882439 · COMPLETED

Trial details

NCT number
NCT01882439
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriatic Arthritis
Start date
2013-08-01
Primary completion
2016-04-01
Enrollment
395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.